Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
Quick Stats
Jan 30, 202650.1
AI Score
HOLD0.52
Volume Ratio
Mar 12, 2026
Next Earnings
21
+ve Days (30d)
9
-ve Days (30d)
LPCN Stock Summary
Last updated Jan 30, 2026
LPCN is currently trading at $9, positioned above its 200-day moving average of $3.84, indicating a long-term uptrend. The stock has a 52-week range of $2.52 to $12.37.
Technical Analysis: The 50-day moving average stands at $6.09, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.818, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.206, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates LPCN at 50.1/100 with a HOLD recommendation.
LPCN (Lipocine Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.818 |
| CMF (20) | 0.206 |
| ROC (10) | -20.071 |
| ADX (14) | 47.214 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.067 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -77.117 |
| MFI (14) | 65.099 |
LPCN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LPCN Price vs Max Options Open Interest
LPCN Max Change In Options Open Interest
LPCN Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LPCN Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LPCN Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LPCN Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lipocine Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
LPCN Moving Averages Analysis
Lipocine Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Lipocine Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
LPCN (Lipocine Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 10.06 |
| 20 | 9.41 |
| 30 | 8.0 |
| 50 | 6.09 |
| 100 | 4.49 |
| 200 | 3.84 |
LPCN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 52.5 million |
| Earnings/Share ($) | -1.02 |
| Net Proft Margin (%) | -1.2666 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.965 |
| EPS Estimate Next Year ($) | -1.81 |
| WallStreet Target Price ($) | 10.875 |
| Most Recent Quarter |